MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ
2.510
-0.120
-4.56%
After Hours: 2.510 0 0.00% 17:17 03/27 EDT
OPEN
2.550
PREV CLOSE
2.630
HIGH
2.660
LOW
2.450
VOLUME
6.66K
TURNOVER
--
52 WEEK HIGH
10.28
52 WEEK LOW
2.120
MARKET CAP
5.94M
P/E (TTM)
-0.2149
1D
5D
1M
3M
1Y
5Y
1D
XTL Biopharmaceuticals trading halted, news pending
TipRanks · 3d ago
XTL Biopharmaceuticals CFO Niv Segal Files Initial Beneficial Ownership Statement
Reuters · 4d ago
Weekly Report: what happened at XTLB last week (0316-0320)?
Weekly Report · 4d ago
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
TipRanks · 5d ago
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
TipRanks · 03/20 20:27
XTL Biopharmaceuticals announces 1-for-4 ADS ratio change
Seeking Alpha · 03/20 20:19
X T L BIOPHARMACEUTICALS LTD - XTL BIOPHARMACEUTICALS TO CHANGE ADS RATIO FROM 1:100 TO 1:400 EFFECTIVE MARCH 25, 2026
Reuters · 03/20 20:12
XTL Biopharma To Implement 1-For-4 Reverse ADS Split, Effective March 25, 2026
Benzinga · 03/20 20:10
More
About XTLB
X T L Biopharmaceuticals Ltd (Xenograft Technologies Ltd) is an Israel-based biopharmaceutical company engaged in acquisition and development of pharmaceutical drugs for treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong a survival of patients for treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by kidneys. EPO stimulates erythropoiesis, production of red blood cells, by binding to its receptor on a surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ: XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.